Search Results - "Pohlreich, D"

Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party by Robinson, S P, Boumendil, A, Finel, H, Blaise, D, Poiré, X, Nicolas-Virelizier, E, Or, R, Malladi, R, Corby, A, Fornecker, L, Caballero, D, Pohlreich, D, Nagler, A, Thieblemont, C, Finke, J, Bachy, E, Vincent, L, Schroyens, W, Schouten, H, Dreger, P

“…In the era of chemoimmunotherapy, the optimal treatment paradigm for relapsed and refractory diffuse large B-cell lymphoma has been challenged. We reviewed the…”
Get full text

The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT by Robinson, S P, Canals, C, Luang, J J, Tilly, H, Crawley, C, Cahn, J Y, Pohlreich, D, Le Gouill, S, Gilleece, M, Milpied, N, Attal, M, Biron, P, Maury, S, Rambaldi, A, Maertens, J, Capria, S, Colombat, P, Montoto, S, Sureda, A

“…Both auto-SCT and reduced intensity allo-SCT (RIST) are employed in the treatment of relapsed follicular lymphoma (FL). We have analysed the outcome of these…”
Get full text

Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party by Bento, L, Boumendil, A, Finel, H, Le Gouill, S, Amorim, S, Monjanel, H, Bouabdallah, R, Bay, J O, Nicolas-Virelizier, E, McQuaker, G, Rossi, G, Johnson, R, Huynh, A, Ceballos, P, Rambaldi, A, Bachy, E, Malladi, R, Orchard, K, Pohlreich, D, Tilly, H, Bonifazi, F, Poiré, X, Guilhot, F, Haenel, A, Crawley, C, Metzner, B, Gribben, J, Russell, N H, Damaj, G, Thomson, K, Dreger, P, Montoto, S

“…Relapse remains the most common cause of treatment failure in patients receiving autologous stem cell transplantation (ASCT) for follicular lymphoma (FL). The…”
Get full text

KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12 12 HLA matched, hematopoietic stem cell transplantation by Ludajic, K, Balavarca, Y, Bickeböller, H, Rosenmayr, A, Fae, I, Fischer, G F, Kouba, M, Pohlreich, D, Kalhs, P, Greinix, H T

“…Interactions of polymorphic killer Ig-like receptor (KIR) receptors with KIR ligands have been shown to modify the outcome of hematopoietic SCT (HSCT). The…”
Get full text

Comparison of three single platform methods for CD34+ hematopoietic stem cell enumeration by flow cytometry by Marinov, I, Luxova, A, Tkacova, V, Gasova, Z, Pohlreich, D, Cetkovsky, P

“…In the present study, we compared three single platform methods for CD34+ hematopoietic stem cell (HSC) enumeration by flow cytometry. For this purpose, we…”
Get more information

The effect of allogeneic stem cell transplantation on high risk chronic lymphocytic leukaemia: a single centre retrospective analysis by Válková, V, Schwarz, J, Vítek, A, Marková, M, Pohlreich, D, Benešová, K, Michalová, K, Cetkovský, P, Trněný, M

“…In recent years, many studies have confirmed that allogeneic stem cell transplantation (allo‐SCT) can provide long‐term disease control and possible cure in…”
Get full text

Retrospective analysis of the results of high-dose chemotherapy with the support of autologous blood stem cells in patients with multiple myeloma. The experience of a single centre by Kořen, J, Spička, I, Straub, J, Vacková, B, Trnková, M, Pohlreich, D, Pytlík, R, Trněný, M

“…Despite new medical products introduced in multiple myeloma therapy, autologous stem cell transplant (ASCT) remains a standard procedure in younger patients…”
Get more information

Echocardiographic evaluation of acute cardiotoxicity in the treatment of Hodgkin disease according to the German Hodgkin's Lymphoma Study Group by Krupicka, J, Marková, J, Pohlreich, D, Kozák, T, Línková, H, Diehl, V

“…Echocardiography is a sensitive method for detecting wall motion abnormalities, as well as for monitoring cardiotoxicity during treatment with anthracyclines…”
Get full text

Thrombelastography monitoring of platelet substitution therapy and rFVIIa administration in haemato-oncological patients with severe thrombocytopenia by Salaj, P, Marinov, I, Marková, M, Pohlreich, D, Cetkovský, P, Hrachovinová, I

“…Thrombocytopenic patients refractory to platelet concentrates (PC) could be treated during bleeding episodes with the recombinant activated FVII (rFVIIa)…”
Get more information

Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party by Greco, Raffaella, Bondanza, Attilio, Oliveira, Maria Carolina, Badoglio, Manuela, Burman, Joachim, Piehl, Fredrik, Hagglund, Hans, Krasulova, Eva, Simões, Belinda Pinto, Carlson, Kristina, Pohlreich, David, Labopin, Myriam, Saccardi, Riccardo, Comi, Giancarlo, Mancardi, Gian Luigi, Bacigalupo, Andrea, Ciceri, Fabio, Farge, Dominique

“…Background: Neuromyelitis optica (NMO) is an inflammatory autoimmune disorder of the central nervous system, hallmarked by pathogenic anti-aquaporin 4…”
Get full text

Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixafor by Morris, Curly, Chabannon, Christian, Masszi, Tamas, Russell, Nigel, Nahi, Hareth, Kobbe, Guido, Krejci, Marta, Auner, Holger W., Pohlreich, David, Hayden, Patrick, Basak, Grzegorz W., Lenhoff, Stig, Schaap, Nicolaas, van Biezen, Anja, Knol, Cora, Iacobelli, Simona, Liu, Qianying, Celanovic, Marina, Garderet, Laurent, Kröger, Nicolaus

“…Plerixafor plus granulocyte-colony stimulating factor (G-CSF) enhances the mobilization of hematopoietic stem cells (HSCs) for collection and subsequent…”
Get full text

Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor by Sureda, Anna, Chabannon, Christian, Masszi, Tamás, Pohlreich, David, Scheid, Christof, Thieblemont, Catherine, Wahlin, Björn E., Sakellari, Ioanna, Russell, Nigel, Janikova, Andrea, Dabrowska-Iwanicka, Anna, Touzeau, Cyrille, Esquirol, Albert, Jantunen, Esa, van der Werf, Steffie, Bosman, Paul, Boumendil, Ariane, Liu, Qianying, Celanovic, Marina, Montoto, Silvia, Dreger, Peter

“…Plerixafor + granulocyte-colony stimulating factor (G-CSF) is administered to patients with lymphoma who are poor mobilizers of hematopoietic stem cells (HSCs)…”
Get full text

High‐dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL‐GITMO by Avivi, Irit, Arcaini, Luca, Ferretti, Virginia V., Boumendil, Ariane, Finel, Hervé, Milone, Giuseppe, Zaja, Francesco, Liliana, Devizzi, Musso, Maurizio, Didier, Blaise, Bachy, Emmanuel, Wattad, Mohammed, Nicolas‐Virelizier, Emmanuelle, Gramatzki, Martin, Bourhis, Jean‐Henri, Caillot, Denis, Haenel, Anette, Held, Gerhard, Thieblemont, Catherine, Jindra, Pavel, Pohlreich, David, Guilhot, François, Kroschinsky, Frank, Wahlin, Björn, Scheid, Christof, Ifrah, Norbert, Berthou, Christian, Dreger, Peter, Montoto, Silvia, Conconi, Annarita

“…Summary The role of autologous stem cell transplantation (ASCT) in patients with marginal zone lymphoma (MZL) is debatable. This study investigated the outcome…”
Get full text

257: Decrease of HHV6 DNAemia following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chromosomally Integrated HHV6 by Hubacek, P, Hrdlickova, A, Muzikova, K, Hyncicova, K, Pohlreich, D, Cetkovsky, P, Sedlacek, P

Get full text

Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation by Malladi, R, Russell, N H, Crawley, C, Orchard, K, Haenel, A, Gribben, J, Pohlreich, D, Tilly, H, Guilhot, F, Thomson, K, Bento, L, Bay, J O, Poiré, X, Rambaldi, A, Boumendil, A, Damaj, G, Bouabdallah, R, Huynh, A, Rossi, G, Bonifazi, F, Bachy, E, Monjanel, H, Finel, H, Ceballos, P, Nicolas-Virelizier, E, Johnson, R, Metzner, B, Amorim, S, Dreger, P, Montoto, S, Le Gouill, S, McQuaker, G

“…Relapse remains the most common cause of treatment failure in patients receiving autologous stem cell transplantation (ASCT) for follicular lymphoma (FL). The…”
Get full text

Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation : a retrospective study of the EBMT Lymphoma Working Party by Bento, L, Boumendil, A, Finel, H, Le Gouill, S, Amorim, S, Monjanel, H, Bouabdallah, R, Bay, J O, Nicolas-Virelizier, E, McQuaker, G, Rossi, G, Johnson, R, Huynh, A, Ceballos, P, Rambaldi, A, Bachy, E, Malladi, R, Orchard, K, Pohlreich, D, Tilly, H, Bonifazi, F, Poiré, X, Guilhot, F, Haenel, A, Crawley, C, Metzner, B, Gribben, J, Russell, N H, Damaj, G, Thomson, K, Dreger, P, Montoto, S

“…Relapse remains the most common cause of treatment failure in patients receiving autologous stem cell transplantation (ASCT) for follicular lymphoma (FL). The…”
Get full text

Salvage Treatment and the Role of Transplantation in Lymphomas by Pohlreich, D, Vacková, B, Pytlík, R, Trnková, M, Trněný, M

“…Despite achieving promising treatment results in patients with lymphoma, there is still a significant proportion of patients who relapse or have refractory…”
Get more information

Gemtuzumab ozogamicin prior to conditioning regimen before allogeneic haematopoietic stem cell transplantation may lead to acceptable outcome in high-risk acute myeloid leukaemia patients by Markova, M, Valkova, V, Vitek, A, Klamova, H, Pohlreich, D, Cetkovsky, P

“…Introduction: Although allogeneic haematopoietic stem cell transplantation leads to durable remission in many intermediate and high-risk acute leukemia…”
Get full text

Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Myeloma Patients Receiving Plerixafor by Morris, C, Chabannon, C, Masszi, T, Russell, N, Nahi, H, Kobbe, G, Krejci, M, Auner, H, Pohlreich, D, Hayden, P, Basak, GW, Lenhoff, S, Schaap, N, van Biezen, A, Knol, C, Lacobelli, S, Liu, QY, Celanovic, M, Garderet, L, Kroger, N

Get full text

Decreased risk of acute gastrointestinal toxicity when substituting methotrexate with mycophenolate mofetil in the prevention of graft-versus-host disease in stem cell transplantation following myeloablative conditioning regimens by Pohlreich, D, Vitek, A, Maalouf, J, Cetkovsky, P

Get full text